Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
about
Overexpression of Mitochondrial GTPase MFN2 Represents a Negative Prognostic Marker in Human Gastric Cancer and Its Inhibition Exerts Anti-Cancer Effects.SOX4 expression is associated with treatment failure and chemoradioresistance in oral squamous cell carcinoma.Upregulated Expression of SOX4 Is Associated with Tumor Growth and Metastasis in Nasopharyngeal Carcinoma.SOX4 Promotes Progression in OLP-Associated Squamous Cell Carcinoma.Histological and Pathological Assessment of miR-204 and SOX4 Levels in Gastric Cancer Patients.EPAC1 overexpression is a prognostic marker and its inhibition shows promising therapeutic potential for gastric cancer.SOX4 is a potential prognostic factor in human cancers: a systematic review and meta-analysis.Overexpression of PCDHB9 promotes peritoneal metastasis and correlates with poor prognosis in patients with gastric cancer.SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.Clinicopathological features of gastric adenocarcinoma patients with metachronous distant metastasis.SOX4 expression is closely associated with differentiation and lymph node metastasis in oral squamous cell carcinoma.Enhanced intensity on preoperative double contrast-enhanced sonography as a useful indicator of lymph node metastasis in patients with gastric cancer.SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.Loss of cyclin-dependent kinase-like 2 predicts poor prognosis in gastric cancer, and its overexpression suppresses cells growth and invasion.MicroRNA-539 inhibits colorectal cancer progression by directly targeting SOX4.
P2860
Q33776682-9495BC73-C01B-456A-82D3-34008E07697BQ35837268-6727A08D-8388-486B-B663-69B91642FFF1Q36249545-C3055FF1-FDC7-4CC7-9C5F-1D7EA1F1AD43Q37133681-DEFFBDAF-8FA3-4E17-A771-BEA748F3B208Q37590870-F0F8F400-D0A9-44CF-9883-4DE97330AF14Q37722152-7B0C6E6C-40EB-4EA2-A127-91F84FCA5A53Q38562153-7FCE8E13-28BB-4822-A0EB-682547949450Q38698251-2C15643D-1DF3-4847-9FF2-08D54DD3616EQ40813966-C3016FA1-4B49-4ACB-B174-2F81EE05FB9AQ41002921-0ED75918-D10F-4A5A-B616-5553CBDA33BEQ43835062-8B706BE8-5B1D-42A1-B020-42A88143213FQ44271698-D9EE3DEB-202F-4E9D-8552-2D516C3C6AC7Q53643055-17F9D6EB-5153-4E3F-9B06-AEAED142A060Q54978458-3A9ADEE2-AA6E-495D-A92F-CFDF89E91D83Q55665136-EA37BE8D-5F67-48DF-9D61-415176052A8F
P2860
Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
@ast
Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
@en
Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
@nl
type
label
Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
@ast
Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
@en
Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
@nl
prefLabel
Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
@ast
Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
@en
Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
@nl
P2093
P2860
P1433
P1476
Clinical and prognostic association of transcription factor SOX4 in gastric cancer.
@en
P2093
Chia-Lang Fang
Kai-Yuan Lin
Shih-Ting Hung
Yi-Feng Lin
Yih-Huei Uen
You-Cheng Hseu
P2860
P304
P356
10.1371/JOURNAL.PONE.0052804
P407
P577
2012-12-20T00:00:00Z